Skip to content 
Search

Latest Stories

Pakistan to purchase 1.2 million Covid-19 vaccine doses from China's Sinopharm

PAKISTAN will purchase 1.2 million Covid-19 vaccine doses from China's Sinopharm, a minister said on Thursday(31), the first official confirmation of a vaccine purchase by the South Asian country as it battles a second wave of infections.

China approved a Covid-19 vaccine developed by an affiliate of state-backed pharmaceutical giant Sinopharm on Thursday, its first approved shot for general public use.


"The Cabinet Committee has decided to initially purchase 1.2 million doses of the vaccine from the Chinese company Sinopharm, which will be provided free of cost to frontline workers in the first quarter of 2021," Pakistani minister for science and technology Chaudhry Fawad Hussain said on Twitter.

The minister told Reuters the purchase would be of the vaccine candidate developed by Sinopharm's Beijing Institute of Biological Products.

Sinopharm has another candidate, developed by the Wuhan Institute of Biological Products, which is also in phase III trials.

Pakistan earlier this month approved $150 million to buy COVID-19 vaccines, initially to cover the most vulnerable 5 per cent of the population, but did not announce which one it would procure, saying it could tap more than one source.

"If the private sector wants to import any other internationally-approved vaccine, it can," Hussain said on Thursday.

The country of 220 million is in the midst of another spate of infections, with 58 deaths on Wednesday(30) taking its death toll past 10,000. It also reported 2,475 new infections, taking the total to 479,715.

Pakistan is currently running phase III clinical trials for CanSino Biologics' vaccine candidate, Ad5-nCoV, led by the government-run National Institute of Health.

Hassan Abbas of AJ Pharma, CanSino's local representative, has said that recruitment for the trial will be completed in 10 days.

"Preliminary results will be shared 4 or 5 days after recruitment is completed, and these will include the efficacy of the vaccine," Abbas said, adding that thus far there have been no serious side effects.

AJ Pharma is one of five companies that have applied for a license to distribute the vaccine in Pakistan once approved, he added.

More For You

Pakistan rejects claim of China’s role in border clash

Asim Munir

Pakistan rejects claim of China’s role in border clash

PAKISTAN’S army chief Field Marshal Asim Munir on Monday (7) rejected Delhi’s allegation that his military received active support from longtime ally China in its conflict with India in May.

The Indian Army’s deputy chief, Lieutenant General Rahul Singh, said last week that China gave Islamabad “live inputs” on key Indian positions.

Keep ReadingShow less
Modi courts Latin nations to expand trade relations

Christine Kangaloo awards Narendra Modi with the Order of the Republic of Trinidad and Tobago last Friday (4)

Modi courts Latin nations to expand trade relations

INDIA’S prime minister, Narendra Modi met Argentine president Javier Milei in Buenos Aires last Saturday (5), urging the expansion of New Delhi’s preferential trade deal with South America’s Mercosur bloc.

The bilateral talks with Milei were the latest in Modi’s whistle-stop diplomatic tour culminating in the summit of Brics emerging economies which began last Sunday (6) in Brazil.

Keep ReadingShow less
Minister 'open to talks' on British Sikh regiment

Lord Coaker (Photo: UK Parliament)

Minister 'open to talks' on British Sikh regiment

A FRESH parliamentary initiative to establish a dedicated Sikh regiment within the British Army has gained momentum in the House of Lords, with defence minister Lord Coaker expressing willingness to engage in further discussions about the long-debated proposal.

The issue was raised in the House of Lords on Monday (7) by Labour peer Lord Sahota, who asked whether there had been any progress on long-standing calls for a Sikh regiment.

Keep ReadingShow less
Heatwave Alert: Don’t Leave Contraceptives or Medication in Cars

Heat can also damage everyday items like sunglasses, suncream and vape devices

iStock

Drivers warned to remove contraceptives and medication from cars during UK heatwave

Highlights:

  • Experts urge motorists to avoid leaving certain items in vehicles during upcoming heatwave
  • Temperatures expected to rise above 30°C across large parts of the UK
  • Contraceptives and common medications can lose effectiveness in high heat
  • Heat can also damage everyday items like sunglasses, suncream and vape devices

Drivers urged to act as UK braces for extended heatwave

Drivers across the UK are being urged to remove a range of everyday items from their cars ahead of a predicted heatwave, with experts warning that the rising temperatures could pose both safety and health risks.

The Met Office has forecast a prolonged spell of hot weather, with temperatures expected to soar into the low 30s on Thursday and Friday. Much of the UK is likely to hit its regional heatwave threshold by the weekend, with this episode potentially affecting a wider area and lasting longer than previous hot spells.

Keep ReadingShow less
Royal Mail

The Royal Mail logo is seen on the side of a van as the UK government clear a 3.57 billion pound takeover offer by Czech billionaire Daniel Kretinsky in London, December 16, 2024. (Photo: Reuters)

Reuters

Ofcom updates Royal Mail delivery targets, starts pricing review

MEDIA regulator Ofcom has set new minimum delivery standards for Royal Mail and revised existing targets in an effort to reduce delays. It also announced a review into pricing and affordability, amid concerns over rising stamp prices.

Royal Mail, which has faced fines of around $20 million over the past two years for not meeting delivery targets, is currently trying to modernise operations and focus more on parcel deliveries.

Keep ReadingShow less